OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Coxsackievirus B3—Its Potential as an Oncolytic Virus
Anja Geisler, Ahmet Hazini, Lisanne Heimann, et al.
Viruses (2021) Vol. 13, Iss. 5, pp. 718-718
Open Access | Times Cited: 34
Anja Geisler, Ahmet Hazini, Lisanne Heimann, et al.
Viruses (2021) Vol. 13, Iss. 5, pp. 718-718
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
The pyroptotic role of Caspase-3/GSDME signalling pathway among various cancer: A Review
Asif Ahmad Bhat, Riya Thapa, Obaid Afzal, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 124832-124832
Closed Access | Times Cited: 95
Asif Ahmad Bhat, Riya Thapa, Obaid Afzal, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 124832-124832
Closed Access | Times Cited: 95
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
Shashi Gujar, Jonathan Pol, K. Vishnupriyan, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2540-2570
Closed Access | Times Cited: 14
Shashi Gujar, Jonathan Pol, K. Vishnupriyan, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2540-2570
Closed Access | Times Cited: 14
Synergistic Viro-chemoimmunotherapy in Breast Cancer Enabled by Bioengineered Immunostimulatory Exosomes and Dual-Targeted Coxsackievirus B3
Amirhossein Bahreyni, Yasir Mohamud, Sanaz Ashraf Nouhegar, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4241-4255
Open Access | Times Cited: 12
Amirhossein Bahreyni, Yasir Mohamud, Sanaz Ashraf Nouhegar, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4241-4255
Open Access | Times Cited: 12
Global landscape of coxsackieviruses in human health
Raiana Scerni Machado, Fernando Neto Tavares, Ivanildo P. Sousa
Virus Research (2024) Vol. 344, pp. 199367-199367
Open Access | Times Cited: 10
Raiana Scerni Machado, Fernando Neto Tavares, Ivanildo P. Sousa
Virus Research (2024) Vol. 344, pp. 199367-199367
Open Access | Times Cited: 10
Oncolytic Viruses and Immune Checkpoint Inhibitors: The “Hot” New Power Couple
Charlotte Lovatt, Alan L. Parker
Cancers (2023) Vol. 15, Iss. 16, pp. 4178-4178
Open Access | Times Cited: 14
Charlotte Lovatt, Alan L. Parker
Cancers (2023) Vol. 15, Iss. 16, pp. 4178-4178
Open Access | Times Cited: 14
Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Cytokine response to coxsackievirus B3 infection
Shivani Singh, Anil Kumar Singh, Ambuj Kumar Kushwaha
Elsevier eBooks (2025), pp. 113-125
Closed Access
Shivani Singh, Anil Kumar Singh, Ambuj Kumar Kushwaha
Elsevier eBooks (2025), pp. 113-125
Closed Access
Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies
Dirk M. Nettelbeck, Mathias F. Leber, Jennifer Altomonte, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1420-1420
Open Access | Times Cited: 26
Dirk M. Nettelbeck, Mathias F. Leber, Jennifer Altomonte, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1420-1420
Open Access | Times Cited: 26
A new miRNA-Modified coxsackievirus B3 inhibits triple negative breast cancer growth with improved safety profile in immunocompetent mice
Amirhossein Bahreyni, Huitao Liu, Yasir Mohamud, et al.
Cancer Letters (2022) Vol. 548, pp. 215849-215849
Open Access | Times Cited: 17
Amirhossein Bahreyni, Huitao Liu, Yasir Mohamud, et al.
Cancer Letters (2022) Vol. 548, pp. 215849-215849
Open Access | Times Cited: 17
Coxsackievirus Group B3 Has Oncolytic Activity against Colon Cancer through Gasdermin E-Mediated Pyroptosis
Yejia Zhang, Tian Xu, Huizhen Tian, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6206-6206
Open Access | Times Cited: 16
Yejia Zhang, Tian Xu, Huizhen Tian, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6206-6206
Open Access | Times Cited: 16
A combination of genetically engineered oncolytic virus and melittin-CpG for cancer viro-chemo-immunotherapy
Amirhossein Bahreyni, Huitao Liu, Yasir Mohamud, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Amirhossein Bahreyni, Huitao Liu, Yasir Mohamud, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320
M. Girod, Anja Geisler, Luisa Hinze, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5618-5618
Open Access | Times Cited: 3
M. Girod, Anja Geisler, Luisa Hinze, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5618-5618
Open Access | Times Cited: 3
miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses
Мария Сергеевна Торопко, Sergey Chuvpilo, Alexander Karabelsky
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 986-986
Open Access | Times Cited: 3
Мария Сергеевна Торопко, Sergey Chuvpilo, Alexander Karabelsky
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 986-986
Open Access | Times Cited: 3
Pathogenesis of enterovirus infection in central nervous system
Congcong Wang, Jichen Li, Ying Liu, et al.
Biosafety and Health (2023) Vol. 5, Iss. 4, pp. 233-239
Open Access | Times Cited: 7
Congcong Wang, Jichen Li, Ying Liu, et al.
Biosafety and Health (2023) Vol. 5, Iss. 4, pp. 233-239
Open Access | Times Cited: 7
Oncolytic Viruses and Immune Checkpoint Inhibitors: The “Hot” New Power Couple
Charlotte Lovatt, Alan L. Parker
(2023)
Open Access | Times Cited: 7
Charlotte Lovatt, Alan L. Parker
(2023)
Open Access | Times Cited: 7
Strategies for engineering oncolytic viruses to enhance cancer immunotherapy
Ziyang Steve Yin, Zhengfeng Wang
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Ziyang Steve Yin, Zhengfeng Wang
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Coxsackievirus B3 Activates Macrophages Independently of CAR-Mediated Viral Entry
Yasir Mohamud, Jingfei Carly Lin, Sinwoo Wendy Hwang, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1456-1456
Open Access | Times Cited: 2
Yasir Mohamud, Jingfei Carly Lin, Sinwoo Wendy Hwang, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1456-1456
Open Access | Times Cited: 2
Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors
Bopei Cui, Lifang Song, Qian Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Bopei Cui, Lifang Song, Qian Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Breaking the barriers in cancer care: The next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment
Nikhil I. Khushalani, Kevin J. Harrington, Alan Melcher, et al.
Molecular Therapy — Oncolytics (2023) Vol. 31, pp. 100729-100729
Open Access | Times Cited: 4
Nikhil I. Khushalani, Kevin J. Harrington, Alan Melcher, et al.
Molecular Therapy — Oncolytics (2023) Vol. 31, pp. 100729-100729
Open Access | Times Cited: 4
Oncolytic activity of a coxsackievirus B3 strain in patient-derived cervical squamous cell carcinoma organoids and synergistic effect with paclitaxel
Yanzhen Lin, Nanyi Liu, Chuanlai Yang, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Yanzhen Lin, Nanyi Liu, Chuanlai Yang, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Oncolytic Coxsackievirus B3 Strain PD-H Is Effective Against a Broad Spectrum of Pancreatic Cancer Cell Lines and Induces a Growth Delay in Pancreatic KPC Cell Tumors In Vivo
Anja Geisler, Babette Dieringer, Leslie Elsner, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11224-11224
Open Access | Times Cited: 1
Anja Geisler, Babette Dieringer, Leslie Elsner, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11224-11224
Open Access | Times Cited: 1
Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
Ahmet Hazini, Babette Dieringer, Karin Klingel, et al.
Viruses (2021) Vol. 13, Iss. 10, pp. 1918-1918
Open Access | Times Cited: 9
Ahmet Hazini, Babette Dieringer, Karin Klingel, et al.
Viruses (2021) Vol. 13, Iss. 10, pp. 1918-1918
Open Access | Times Cited: 9
A promising future in cancer immunotherapy: Oncolytic viruses
Seyed Mahmood Seyed Khorrami, Arezou Azadi, Nasrin Rastegarvand, et al.
European Journal of Pharmacology (2023) Vol. 960, pp. 176063-176063
Closed Access | Times Cited: 3
Seyed Mahmood Seyed Khorrami, Arezou Azadi, Nasrin Rastegarvand, et al.
European Journal of Pharmacology (2023) Vol. 960, pp. 176063-176063
Closed Access | Times Cited: 3
Oncolytic viruses in hematological malignancies: hijacking disease biology and fostering new promises for immune and cell-based therapies
Mário Sousa‐Pimenta, Ângelo Martins, Vera Machado
International review of cell and molecular biology (2023), pp. 189-219
Closed Access | Times Cited: 2
Mário Sousa‐Pimenta, Ângelo Martins, Vera Machado
International review of cell and molecular biology (2023), pp. 189-219
Closed Access | Times Cited: 2
Current status and research progress of oncolytic virus
Yingyu Chen, Mengyuan Tao, Xuwei Wu, et al.
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100037-100037
Open Access
Yingyu Chen, Mengyuan Tao, Xuwei Wu, et al.
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100037-100037
Open Access
